High materiality8/10
Capricor Therapeutics upgraded to Overweight from Neutral at Piper Sandler
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler upgrades CAPR to Overweight from Neutral; target $25; current price $9.91.
- Piper Sandler upgrades CAPR to Overweight; target $25; price $9.91.
Key facts
- 01
Target: $25
- 02
Posted price: $9.91
- 03
Analyst firm: Piper Sandler
- 04
Analyst: Edward Tenthoff
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.